FONAR Corporation (FONR)
USD 13.8
(1.92%)
USD 13.8
(1.92%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | 28.25 Million USD | 14.78% |
| 2023 | 24.61 Million USD | -25.51% |
| 2022 | 31.65 Million USD | 35.7% |
| 2021 | 23.45 Million USD | 68.65% |
| 2020 | 19.13 Million USD | -38.01% |
| 2019 | 25.97 Million USD | 12.48% |
| 2018 | 23.84 Million USD | 4.11% |
| 2017 | 22.62 Million USD | 29.95% |
| 2016 | 18.06 Million USD | 9.41% |
| 2015 | 17.06 Million USD | 13.69% |
| 2014 | 15.75 Million USD | 19.15% |
| 2013 | 10.9 Million USD | 1.39% |
| 2012 | 9.72 Million USD | 58.88% |
| 2011 | 5.97 Million USD | 795.95% |
| 2010 | -1.17 Million USD | -183.35% |
| 2009 | 3.23 Million USD | 103.92% |
| 2008 | -10.18 Million USD | -12.36% |
| 2007 | -22.77 Million USD | 8.15% |
| 2006 | -25.96 Million USD | -8753.54% |
| 2005 | 6.35 Million USD | 104.08% |
| 2004 | -6.92 Million USD | 51.82% |
| 2003 | -13.05 Million USD | 10.55% |
| 2002 | -16.65 Million USD | 10.59% |
| 2001 | -13.84 Million USD | 0.93% |
| 2000 | -11.75 Million USD | -36.53% |
| 1999 | -10.9 Million USD | 47.78% |
| 1998 | -14.7 Million USD | 74.5% |
| 1997 | -22.4 Million USD | -733.86% |
| 1996 | -11.1 Million USD | -30.93% |
| 1995 | -4.1 Million USD | -193.94% |
| 1994 | 100 Thousand USD | 15.38% |
| 1993 | 400 Thousand USD | -262.5% |
| 1992 | 3.3 Million USD | -40.0% |
| 1991 | 6.4 Million USD | -23.81% |
| 1990 | 8.4 Million USD | 205.0% |
| 1989 | -8 Million USD | -216.45% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | 6.01 Million USD | -27.86% |
| 2024 Q2 | 7.8 Million USD | -10.32% |
| 2024 Q1 | 6.57 Million USD | 83.2% |
| 2024 Q4 | 3.44 Million USD | -33.37% |
| 2023 Q4 | 4.62 Million USD | -27.41% |
| 2023 FY | - USD | -25.51% |
| 2023 Q1 | 6.1 Million USD | -1.38% |
| 2023 Q2 | 6.3 Million USD | 3.28% |
| 2023 Q3 | 6.36 Million USD | 1.06% |
| 2022 FY | - USD | 35.7% |
| 2022 Q1 | 8.36 Million USD | 59.69% |
| 2022 Q4 | 6.18 Million USD | -23.38% |
| 2022 Q3 | 8.07 Million USD | 23.64% |
| 2022 Q2 | 6.53 Million USD | -21.97% |
| 2021 Q3 | 4.97 Million USD | -28.8% |
| 2021 FY | - USD | 68.65% |
| 2021 Q1 | 5.93 Million USD | 890.67% |
| 2021 Q2 | 6.99 Million USD | 17.89% |
| 2021 Q4 | 5.24 Million USD | 5.28% |
| 2020 Q4 | 598.68 Thousand USD | -77.11% |
| 2020 FY | - USD | -38.01% |
| 2020 Q1 | 7.3 Million USD | 46.18% |
| 2020 Q2 | 6.86 Million USD | -5.95% |
| 2020 Q3 | 2.61 Million USD | -61.91% |
| 2019 FY | - USD | 12.48% |
| 2019 Q1 | 6.45 Million USD | 14.36% |
| 2019 Q3 | 7.58 Million USD | 9.43% |
| 2019 Q4 | 4.99 Million USD | -34.17% |
| 2019 Q2 | 6.93 Million USD | 7.32% |
| 2018 Q3 | 5.38 Million USD | -7.22% |
| 2018 Q2 | 5.8 Million USD | 21.37% |
| 2018 FY | - USD | 4.11% |
| 2018 Q4 | 5.64 Million USD | 4.86% |
| 2018 Q1 | 4.78 Million USD | 6.61% |
| 2017 Q4 | 4.48 Million USD | -34.71% |
| 2017 FY | - USD | 29.95% |
| 2017 Q1 | 5.6 Million USD | 64.96% |
| 2017 Q2 | 5.47 Million USD | -2.39% |
| 2017 Q3 | 6.87 Million USD | 25.58% |
| 2016 Q3 | 4.92 Million USD | -2.88% |
| 2016 Q4 | 3.39 Million USD | -31.02% |
| 2016 Q1 | 4.44 Million USD | 8.97% |
| 2016 Q2 | 5.07 Million USD | 14.15% |
| 2016 FY | - USD | 9.41% |
| 2015 Q3 | 3.55 Million USD | -20.72% |
| 2015 Q4 | 4.07 Million USD | 14.72% |
| 2015 FY | - USD | 13.69% |
| 2015 Q2 | 4.48 Million USD | 3.65% |
| 2015 Q1 | 4.32 Million USD | 17.78% |
| 2014 FY | - USD | 19.15% |
| 2014 Q1 | 3.9 Million USD | 25.43% |
| 2014 Q2 | 4.26 Million USD | 9.35% |
| 2014 Q3 | 3.29 Million USD | -22.87% |
| 2014 Q4 | 3.67 Million USD | 11.61% |
| 2013 Q1 | 2.35 Million USD | -6.15% |
| 2013 Q4 | 3.11 Million USD | 34.73% |
| 2013 Q3 | 2.3 Million USD | 34.4% |
| 2013 Q2 | 1.71 Million USD | -26.89% |
| 2013 FY | - USD | 1.39% |
| 2012 Q3 | 2.23 Million USD | -9.91% |
| 2012 Q2 | 2.48 Million USD | 5.71% |
| 2012 Q1 | 2.34 Million USD | 96.38% |
| 2012 FY | - USD | 58.88% |
| 2012 Q4 | 2.5 Million USD | 11.99% |
| 2011 Q3 | 2.05 Million USD | 3.59% |
| 2011 Q4 | 1.19 Million USD | -41.68% |
| 2011 Q2 | 1.97 Million USD | 196.7% |
| 2011 FY | - USD | 795.95% |
| 2011 Q1 | 667 Thousand USD | -2.71% |
| 2010 Q2 | -968 Thousand USD | 17.69% |
| 2010 Q1 | -1.17 Million USD | 10.54% |
| 2010 FY | - USD | -183.35% |
| 2010 Q4 | 685.55 Thousand USD | 2439.08% |
| 2010 Q3 | 27 Thousand USD | 102.79% |
| 2009 Q4 | -1.31 Million USD | -209.83% |
| 2009 Q2 | 1.01 Million USD | 135.2% |
| 2009 Q3 | 1.19 Million USD | 17.47% |
| 2009 Q1 | -2.89 Million USD | 70.8% |
| 2009 FY | - USD | 103.92% |
| 2008 Q4 | -9.91 Million USD | -332.07% |
| 2008 FY | - USD | -12.36% |
| 2008 Q2 | -3.48 Million USD | 54.73% |
| 2008 Q1 | -7.7 Million USD | 7.41% |
| 2008 Q3 | -2.29 Million USD | 34.17% |
| 2007 FY | - USD | 8.15% |
| 2007 Q4 | -8.31 Million USD | -71.36% |
| 2007 Q3 | -4.85 Million USD | 3.0% |
| 2007 Q2 | -5 Million USD | 11.81% |
| 2007 Q1 | -5.67 Million USD | 21.65% |
| 2006 FY | - USD | -8753.54% |
| 2006 Q4 | -7.24 Million USD | -7.6% |
| 2006 Q3 | -6.72 Million USD | -5.04% |
| 2006 Q2 | -6.4 Million USD | -14.66% |
| 2006 Q1 | -5.58 Million USD | -462.64% |
| 2005 Q2 | 822 Thousand USD | 40.03% |
| 2005 FY | - USD | 104.08% |
| 2005 Q4 | -992.99 Thousand USD | -1404.54% |
| 2005 Q1 | 587 Thousand USD | -55.66% |
| 2005 Q3 | -66 Thousand USD | -108.03% |
| 2004 Q4 | 1.32 Million USD | 175.22% |
| 2004 Q1 | -4.08 Million USD | -7.58% |
| 2004 Q2 | -2.83 Million USD | 30.61% |
| 2004 Q3 | -1.76 Million USD | 37.85% |
| 2004 FY | - USD | 51.82% |
| 2003 Q4 | -3.4 Million USD | 36.8% |
| 2003 FY | - USD | 10.55% |
| 2003 Q2 | -2.3 Million USD | -15.11% |
| 2003 Q3 | -5.57 Million USD | -97.5% |
| 2003 Q1 | -1.99 Million USD | 65.88% |
| 2002 Q2 | -3.6 Million USD | -17.26% |
| 2002 FY | - USD | 10.59% |
| 2002 Q4 | -7.52 Million USD | -152.26% |
| 2002 Q3 | -3.5 Million USD | 13.17% |
| 2002 Q1 | -2.4 Million USD | 63.07% |
| 2001 FY | - USD | 0.93% |
| 2001 Q1 | -3.43 Million USD | 54.42% |
| 2001 Q4 | -4.79 Million USD | -1005.04% |
| 2001 Q3 | -2.24 Million USD | 84.59% |
| 2001 Q2 | -3.37 Million USD | -17.35% |
| 2000 Q3 | -2.86 Million USD | 47.59% |
| 2000 Q4 | -3.21 Million USD | -216.33% |
| 2000 FY | - USD | -36.53% |
| 2000 Q1 | -2.22 Million USD | 15.63% |
| 2000 Q2 | -2.8 Million USD | -100.0% |
| 1999 Q2 | -2.6 Million USD | -46.67% |
| 1999 Q3 | -3 Million USD | 20.45% |
| 1999 Q4 | -3.1 Million USD | 8.57% |
| 1999 Q1 | -2.3 Million USD | 79.59% |
| 1999 FY | - USD | 47.78% |
| 1998 FY | - USD | 74.5% |
| 1998 Q4 | -5.7 Million USD | -241.86% |
| 1998 Q2 | -2.9 Million USD | -16.22% |
| 1998 Q3 | -3.5 Million USD | 0.0% |
| 1998 Q1 | -2.6 Million USD | 95.79% |
| 1997 Q3 | -5.2 Million USD | 68.33% |
| 1997 Q1 | -2 Million USD | 58.93% |
| 1997 FY | - USD | -733.86% |
| 1997 Q4 | -14.1 Million USD | -2213.16% |
| 1997 Q2 | -2.6 Million USD | -421.74% |
| 1996 Q2 | -600 Thousand USD | -80.0% |
| 1996 Q4 | -4.4 Million USD | 6.67% |
| 1996 FY | - USD | -30.93% |
| 1996 Q1 | -200 Thousand USD | 94.57% |
| 1996 Q3 | -1.7 Million USD | -566.67% |
| 1995 Q2 | 400 Thousand USD | 500.0% |
| 1995 FY | - USD | -193.94% |
| 1995 Q1 | 200 Thousand USD | 108.33% |
| 1995 Q4 | -4.2 Million USD | -1433.33% |
| 1995 Q3 | -500 Thousand USD | -200.0% |
| 1994 Q4 | 400 Thousand USD | -340.0% |
| 1994 FY | - USD | 15.38% |
| 1994 Q3 | 500 Thousand USD | 138.46% |
| 1994 Q2 | -300 Thousand USD | -8.33% |
| 1994 Q1 | -300 Thousand USD | 76.92% |
| 1993 FY | - USD | -262.5% |
| 1993 Q4 | -1.7 Million USD | -940.0% |
| 1993 Q2 | 900 Thousand USD | 28.57% |
| 1993 Q3 | 200 Thousand USD | -155.56% |
| 1993 Q1 | 800 Thousand USD | 163.64% |
| 1992 FY | - USD | -40.0% |
| 1992 Q1 | 1.5 Million USD | 114.53% |
| 1992 Q2 | 4.4 Million USD | 158.82% |
| 1992 Q3 | 1.1 Million USD | -77.27% |
| 1992 Q4 | -100 Thousand USD | -210.0% |
| 1991 Q2 | 5.4 Million USD | 5.88% |
| 1991 Q1 | 5.1 Million USD | 126.29% |
| 1991 Q4 | -11.7 Million USD | -348.94% |
| 1991 FY | - USD | -56.04% |
| 1991 Q3 | 4.7 Million USD | -12.96% |
| 1990 FY | - USD | 249.18% |
| 1990 Q1 | 8.3 Million USD | 118.61% |
| 1990 Q2 | 8.3 Million USD | 0.0% |
| 1990 Q3 | 8.3 Million USD | 0.0% |
| 1990 Q4 | -19.4 Million USD | -333.73% |
| 1989 Q2 | 11.5 Million USD | 0.0% |
| 1989 Q1 | 11.5 Million USD | 0.0% |
| 1989 FY | - USD | -188.79% |
| 1989 Q4 | -44.6 Million USD | -487.83% |
| 1989 Q3 | 11.5 Million USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Acutus Medical, Inc. | -13.48 Million USD | 309.473% |
| Cerus Corporation | -26.53 Million USD | 206.465% |
| OrthoPediatrics Corp. | -8.38 Million USD | 437.091% |
| PetVivo Holdings, Inc. | -10.49 Million USD | 369.204% |
| Talis Biomedical Corporation | -66.04 Million USD | 142.776% |
| Vivos Therapeutics, Inc. | -16.67 Million USD | 269.425% |
| Inogen, Inc. | -45.67 Million USD | 161.848% |
| Spectral AI, Inc. | -12.26 Million USD | 330.399% |
| Nano-X Imaging Ltd. | -47.69 Million USD | 159.236% |
| CVRx, Inc. | -38.73 Million USD | 172.943% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | 900.781% |
| Helius Medical Technologies, Inc. | -12.1 Million USD | 333.349% |
| Orthofix Medical Inc. | -86.98 Million USD | 132.479% |
| Venus Concept Inc. | -26.11 Million USD | 208.19% |
| Accelerate Diagnostics, Inc. | -49.77 Million USD | 156.763% |
| Bioventus Inc. | -23.07 Million USD | 222.46% |
| BrainsWay Ltd. | -2.31 Million USD | 1322.482% |
| Envoy Medical, Inc. | -18.23 Million USD | 254.905% |
| electroCore, Inc. | -17.76 Million USD | 259.074% |
| IceCure Medical Ltd | -15.25 Million USD | 285.22% |
| Lucid Diagnostics Inc. | -49.75 Million USD | 156.786% |
| Monogram Orthopaedics, Inc. | -16.85 Million USD | 267.608% |
| MaxCyte, Inc. | -44.12 Million USD | 164.022% |
| NeuroOne Medical Technologies Corporation | -11.75 Million USD | 340.316% |
| Nexalin Technology, Inc. | -5.69 Million USD | 596.334% |
| PAVmed Inc | -75.74 Million USD | 137.3% |
| Rapid Micro Biosystems, Inc. | -53.75 Million USD | 152.553% |
| RxSight, Inc. | -41.03 Million USD | 168.844% |
| Sight Sciences, Inc. | -49.41 Million USD | 157.172% |
| SI-BONE, Inc. | -34.44 Million USD | 182.017% |
| TELA Bio, Inc. | -40.63 Million USD | 169.529% |
| TriSalus Life Sciences, Inc. | -58.29 Million USD | 148.461% |
| Treace Medical Concepts, Inc. | -39 Million USD | 172.425% |
| LivaNova PLC | 39.01 Million USD | 27.59% |
| 908 Devices Inc. | -34.02 Million USD | 183.032% |
| Alphatec Holdings, Inc. | -110.59 Million USD | 125.546% |
| Nemaura Medical Inc. | -7.28 Million USD | 487.695% |
| NeuroPace, Inc. | -22.83 Million USD | 223.726% |
| LENSAR, Inc. | -8.71 Million USD | 424.209% |
| Apyx Medical Corporation | -18.11 Million USD | 255.983% |
| Cutera, Inc. | -136.56 Million USD | 120.688% |
| STRATA Skin Sciences, Inc. | -3.38 Million USD | 935.845% |
| BioSig Technologies, Inc. | -28.15 Million USD | 200.357% |
| Anika Therapeutics, Inc. | 2.51 Million USD | -1022.876% |
| ClearPoint Neuro, Inc. | -20.98 Million USD | 234.602% |
| Integra LifeSciences Holdings Corporation | 383.56 Million USD | 92.635% |
| Axonics, Inc. | 7.77 Million USD | -263.364% |
| Outset Medical, Inc. | -153.78 Million USD | 118.37% |
| IRIDEX Corporation | -7.44 Million USD | 479.317% |
| PROCEPT BioRobotics Corporation | -98.09 Million USD | 128.8% |
| IRadimed Corporation | 20.8 Million USD | -35.821% |
| Tivic Health Systems, Inc. | -8.06 Million USD | 450.429% |
| INVO Bioscience, Inc. | -6.88 Million USD | 510.632% |
| Telesis Bio, Inc. | -40.49 Million USD | 169.769% |
| Viemed Healthcare, Inc. | 36.67 Million USD | 22.972% |
| Varex Imaging Corporation | 67.2 Million USD | 57.959% |
| Quipt Home Medical Corp. | 44.07 Million USD | 35.895% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | 359.904% |
| Pulmonx Corporation | -55.09 Million USD | 151.281% |
| Dynatronics Corporation | -976 Thousand USD | 2994.604% |
| Modular Medical, Inc. | -17.1 Million USD | 265.185% |
| ReShape Lifesciences Inc. | -14.48 Million USD | 295.04% |
| Semler Scientific, Inc. | 23.58 Million USD | -19.766% |
| InMode Ltd. | 196.28 Million USD | 85.607% |
| Bruker Corporation | 599 Million USD | 95.284% |
| Cytosorbents Corporation | -28.81 Million USD | 198.059% |
| DexCom, Inc. | 916.7 Million USD | 96.918% |
| Align Technology, Inc. | 799.03 Million USD | 96.464% |
| Viveve Medical, Inc. | -20.61 Million USD | 237.03% |
| ZimVie Inc. | 91.07 Million USD | 68.979% |
| Movano Inc. | -29.12 Million USD | 197.001% |
| Cytek Biosciences, Inc. | -4.4 Million USD | 740.916% |
| Nexalin Technology, Inc. | -5.69 Million USD | 596.334% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | 900.781% |
| Tandem Diabetes Care, Inc. | -194.65 Million USD | 114.514% |
| Profound Medical Corp. | -27.12 Million USD | 204.159% |
| Insulet Corporation | 323.6 Million USD | 91.27% |
| enVVeno Medical Corporation | -25.01 Million USD | 212.925% |
| Surmodics, Inc. | 1.18 Million USD | -2278.078% |
| iCAD, Inc. | -6.56 Million USD | 530.336% |
| Nuwellis, Inc. | -16.35 Million USD | 272.729% |
| Biotricity, Inc. | -8.82 Million USD | 420.013% |
| iRhythm Technologies, Inc. | -96.86 Million USD | 129.167% |
| Aethlon Medical, Inc. | -11.84 Million USD | 338.428% |
| InspireMD, Inc. | -20.91 Million USD | 235.104% |
| PAVmed Inc. | -75.74 Million USD | 137.3% |
| BIOLASE, Inc. | -15.13 Million USD | 286.614% |
| Beyond Air, Inc. | -59.03 Million USD | 147.859% |
| AxoGen, Inc. | -13.32 Million USD | 311.972% |
| Vivani Medical, Inc. | -26.6 Million USD | 206.177% |
| Tactile Systems Technology, Inc. | 24.54 Million USD | -15.12% |
| Inari Medical, Inc. | 7.11 Million USD | -297.182% |
| UFP Technologies, Inc. | 72.74 Million USD | 61.162% |
| QT Imaging Holdings, Inc. | -3.38 Million USD | 934.417% |
| Heart Test Laboratories, Inc. | -6.15 Million USD | 558.928% |
| Tenon Medical, Inc. | -15.52 Million USD | 281.939% |
| Autonomix Medical, Inc. Common Stock | -15.26 Million USD | 285.062% |
| Co-Diagnostics, Inc. | -41.47 Million USD | 168.116% |
| AdaptHealth Corp. | -171.09 Million USD | 116.513% |
| Sintx Technologies, Inc. | -6.6 Million USD | 528.054% |
| NanoVibronix, Inc. | -3.43 Million USD | 922.462% |
| Quanterix Corporation | -38.08 Million USD | 174.174% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | 359.904% |
| Sensus Healthcare, Inc. | 30 Thousand USD | -94071.883% |
| Pacific Biosciences of California, Inc. | -277.28 Million USD | 110.189% |
| TransMedics Group, Inc. | -7.6 Million USD | 471.584% |
| ReWalk Robotics Ltd. | -21.76 Million USD | 229.803% |
| NeuroMetrix, Inc. | -7.09 Million USD | 498.144% |
| Hyperfine, Inc. | -47.06 Million USD | 160.032% |
| Establishment Labs Holdings Inc. | -58.3 Million USD | 148.453% |
| Biomerica, Inc. | -5.99 Million USD | 571.409% |
| Bone Biologics Corporation | 479.57 Thousand USD | -5790.996% |
| AVITA Medical, Inc. | -39.56 Million USD | 171.4% |
| Bluejay Diagnostics, Inc. | -9.17 Million USD | 407.988% |
| Silk Road Medical, Inc | -45.08 Million USD | 162.67% |